Navigation Links
Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
Date:7/9/2008

e preventing the robust activation of platelets needed to cause thrombosis. In a Phase 1a clinical trial, dose-dependent inhibition of serotonin-mediated amplification of platelet aggregation was demonstrated, supporting the preclinical data generated around APD791 and establishing initial clinical validation for APD791's novel mechanism of action.

About Thrombosis

Thrombosis is the formation of a clot, or thrombus, inside a blood vessel that restricts the flow of blood. The formation of a thrombus is often caused by an injury to the wall of a blood vessel. The injury to the blood vessel activates platelets, which then aggregate and adhere to one another as they start to release certain factors, including serotonin, that facilitate thrombosis. Thrombi that form in diseased atherosclerotic arteries of the heart may cause acute coronary syndrome or myocardial infarction, and thrombi that form in the vessels of the brain may cause stroke.

The American Heart Association estimates that in the United States over 13.9 million people alive in 2005 had survived either a myocardial infarction or a stroke. To reduce the risk of future events, many patients receive daily anti-thrombotic therapy.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds target G protein-coupled receptors, an important class of validated drug targets, and includes compounds being evaluated independently and with partners, including Merck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc.

Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company. "APD" is an abbr
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
2. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
3. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
6. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
7. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
8. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
9. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
10. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
11. Isis Pharmaceuticals Conference Call Notice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... , Sept. 3,  2015 About ... vision care products considered for this report are ... readers. These products are primarily used by consumer ... such as Rx lenses and contact lenses require ... and readers are cosmetic products that can be ...
(Date:9/3/2015)... Sept. 3, 2015 About dry eye syndrome ... due to deficient tear production or quick tear evaporation ... two types: aqueous tear deficient dry eye and evaporative ... glands do not produce enough tears, whereas meibomian gland ... lipids to slow tear evaporation and maintain tear stability. ...
(Date:9/3/2015)... , Sept. 3, 2015  As part of its ... heart disease, Marc R. Katz , MD, MPH, ... Secours Heart & Vascular Institute implanted the first HeartMate ... The patient was selected as part of the prestigious ... 60 elite centers in the United States—and the first ...
Breaking Medicine Technology:Vision Care Market in the US 2015-2019 2Global Dry Eye Syndrome Market 2015-2019 2Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 2Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 3Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 4
(Date:9/3/2015)... ... September 03, 2015 , ... Today, Splashtop announced availability ... as part of the LANDESK One Partner program. Splashtop remote desktop ... mobile user experience in remote access and control:, , ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... ) announces the release of her debut book, “Stop Wasting Your Time Blaming ... Book Day (September 6), Hartley’s guide to overcoming life’s obstacles by taking full ...
(Date:9/3/2015)... ... 03, 2015 , ... Girl’s Night Out to benefit Core Compassion Project will ... Kate Road in Monroe, North Carolina. The event food will be provided ... Kate Clyde’s offers off-premise catering and event services from casual to elegant. They are ...
(Date:9/3/2015)... ... 03, 2015 , ... For the second year in a ... list of fastest-growing private companies in America. President and Editor-in-Chief of Inc. ... have demonstrated such remarkably consistent high growth, particularly in the difficult economic environment ...
(Date:9/3/2015)... ... September 03, 2015 , ... B. E. ... been retained to lead a national chief executive officer recruitment for ... in the healthcare industry, B. E. Smith has recently placed more than 1,000 ...
Breaking Medicine News(10 mins):Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 2Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 3Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 4Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 2Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 3Health News:Girl’s Night Out, with Food From Kate Clyde's Catered Creations, to Benefit Core Compassion Project 2Health News:Inc. 5000 Includes Intellicure, Inc., Two Years in a Row 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 3
... Steven Reinberg HealthDay Reporter , THURSDAY, Dec. ... insurance have risen 41 percent since 2003, new research ... buck. In addition, individual deductibles have skyrocketed 77 ... "Health insurance has become increasingly unaffordable for families ...
... Jenifer Goodwin HealthDay Reporter , THURSDAY, Dec. 2 ... the circuitry of brain connections may someday be used to ... in Boston and the University of Utah used MRIs to ... circuitry in 30 males aged 8 to 26 with high-functioning ...
... novel type of biomedical imaging, made possible by new advances ... and sensitive it can capture "video" of blood cells squeezing ... Saar, Christian W. Freudiger, and X. Sunney Xie describe the ... The new technique, based on stimulated Raman scattering (SRS), makes ...
... make a silk purse out of a sow,s ear, but ... with the notoriously bland flavor of pork. They are reporting ... an Italian swine renowned for its good flavor since the ... hog, whose roots date back barely 125 years. Their study ...
... Varnum National Quality Award was presented to Project SEARCH, ... in a ceremony held on Wednesday, December 1, at ... Receiving the award were Project SEARCH co-founder Erin Riehle, ... Dr. Linda Workman, Vice President of the Center for ...
... consumption of so-called energy drinks can improve people,s response ... those benefits disappear as people drink more of the ... Psychological Association. With the growing popularity of ... RockStar, especially among high school and college students, psychologists ...
Cached Medicine News:Health News:Employer Insurance Costs Rising for Workers 2Health News:Employer Insurance Costs Rising for Workers 3Health News:Brain Scan Might Someday Spot Autism 2Health News:Brain Scan Might Someday Spot Autism 3Health News:New microscopy tracks molecules in live tissue at video rate 2Health News:James W. Varnum National Quality Award presented to Project SEARCH 2Health News:James W. Varnum National Quality Award presented to Project SEARCH 3Health News:'Less is more,' when it comes to sugary, high-caffeine energy drinks, researchers say 2Health News:'Less is more,' when it comes to sugary, high-caffeine energy drinks, researchers say 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: